Literature DB >> 23274984

Identification of conserved surface proteins as novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.

Xiabing Chen1, Zhuofei Xu, Lu Li, Huanchun Chen, Rui Zhou.   

Abstract

Actinobacillus pleuropneumoniae is an important swine respiratory pathogen causing great economic losses worldwide. Identification of conserved surface antigenic proteins is helpful for developing effective vaccines. In this study, a genome-wide strategy combined with bioinformatic and experimental approaches, was applied to discover and characterize surface-associated immunogenic proteins of A. pleuropneumoniae. Thirty nine genes encoding outer membrane proteins (OMPs) and lipoproteins were identified by comparative genomics and gene expression profiling as being-highly conserved and stably transcribed in the different serotypes of A. pleuropneumoniae reference strains. Twelve of these conserved proteins were successfully expressed in Escherichia coli and their immunogenicity was estimated by homologous challenge in the mouse model, and then three of these proteins (APJL_0126, HbpA and OmpW) were further tested in the natural host (swine) by homologous and heterologous challenges. The results showed that these proteins could induce high titers of antibodies, but vaccination with each protein individually elicited low protective immunity against A. pleuropneumoniae. This study gives novel insights into immunogenicity of the conserved OMPs and lipoproteins of A. pleuropneumoniae. Although none of the surface proteins characterized in this study could individually induce effective protective immunity against A. pleuropneumoniae, they are potential candidates for subunit vaccines in combination with Apx toxins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23274984     DOI: 10.1007/s12275-012-2214-2

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  29 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

Review 2.  Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection.

Authors:  Janine T Bossé; Håkan Janson; Brian J Sheehan; Amanda J Beddek; Andrew N Rycroft; J Simon Kroll; Paul R Langford
Journal:  Microbes Infect       Date:  2002-02       Impact factor: 2.700

3.  Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis.

Authors:  Prathiba Kurupati; Boon King Teh; Gamini Kumarasinghe; Chit Laa Poh
Journal:  Proteomics       Date:  2006-02       Impact factor: 3.984

4.  Analysis on Actinobacillus pleuropneumoniae LuxS regulated genes reveals pleiotropic roles of LuxS/AI-2 on biofilm formation, adhesion ability and iron metabolism.

Authors:  Lu Li; Zhuofei Xu; Yang Zhou; Tingting Li; Lili Sun; Huanchun Chen; Rui Zhou
Journal:  Microb Pathog       Date:  2011-02-12       Impact factor: 3.738

5.  Outer membrane proteome of Actinobacillus pleuropneumoniae: LC-MS/MS analyses validate in silico predictions.

Authors:  Jacqueline W Chung; Christopher Ng-Thow-Hing; Lorne I Budman; Bernard F Gibbs; John H E Nash; Mario Jacques; James W Coulton
Journal:  Proteomics       Date:  2007-06       Impact factor: 3.984

6.  Polysaccharide capsule and suilysin contribute to extracellular survival of Streptococcus suis co-cultivated with primary porcine phagocytes.

Authors:  Laurentiu Benga; Marcus Fulde; Christina Neis; Ralph Goethe; Peter Valentin-Weigand
Journal:  Vet Microbiol       Date:  2008-05-14       Impact factor: 3.293

Review 7.  Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies.

Authors:  Mahendrasingh Ramjeet; Vincent Deslandes; Julien Gouré; Mario Jacques
Journal:  Anim Health Res Rev       Date:  2008-03-17       Impact factor: 2.615

8.  The heme-binding protein (HbpA) of Haemophilus influenzae as a virulence determinant.

Authors:  Daniel J Morton; Thomas W Seale; Lauren O Bakaletz; Joseph A Jurcisek; Ann Smith; Timothy M VanWagoner; Paul W Whitby; Terrence L Stull
Journal:  Int J Med Microbiol       Date:  2009-05-17       Impact factor: 3.473

9.  Bacterial surface proteins and vaccines.

Authors:  Guido Grandi
Journal:  F1000 Biol Rep       Date:  2010-05-11

10.  Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae.

Authors:  Falk Fr Buettner; Sarah A Konze; Alexander Maas; Gerald F Gerlach
Journal:  Proteome Sci       Date:  2011-04-20       Impact factor: 2.480

View more
  4 in total

1.  Identification and characterization of a novel stress-responsive outer membrane protein Lip40 from Actinobacillus pleuropneumoniae.

Authors:  Xuehe Hu; Hao Yan; Ke Liu; Jiansheng Hu; Chao Qi; Jihong Yang; Yanli Liu; Jin Zhao; Jinlin Liu
Journal:  BMC Biotechnol       Date:  2015-11-25       Impact factor: 2.563

2.  Comparative proteomic analysis of the membrane proteins of two Haemophilus parasuis strains to identify proteins that may help in habitat adaptation and pathogenesis.

Authors:  Luhua Zhang; Yiping Wen; Ying Li; Xingliang Wei; Xuefeng Yan; Xintian Wen; Rui Wu; Xiaobo Huang; Yong Huang; Qigui Yan; Mafeng Liu; Sanjie Cao
Journal:  Proteome Sci       Date:  2014-07-07       Impact factor: 2.480

3.  A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model.

Authors:  Kui Xu; Qin Zhao; Xintian Wen; Rui Wu; Yiping Wen; Xiaobo Huang; Yong Huang; Qigui Yan; Xinfeng Han; Xiaoping Ma; Yung-Fu Chang; Sanjie Cao
Journal:  PLoS One       Date:  2018-01-26       Impact factor: 3.240

4.  Genome-wide screening of lipoproteins in Actinobacillus pleuropneumoniae identifies three antigens that confer protection against virulent challenge.

Authors:  Yurou Cao; Lulu Gao; Li Zhang; Lixiang Zhou; Jihong Yang; Lingfu Deng; Jin Zhao; Chao Qi; Jinlin Liu
Journal:  Sci Rep       Date:  2020-02-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.